PEP Earnings 'Less Bad Than Expected,' 'Ozempic Effect' Cuts Into Profits

PepsiCo (PEP) rallied on today's earnings, with Alexis Browne Roberts noting a "surprisingly resilient" consumer lifting the numbers. However, she still wouldn't buy the stock even after today's report, giving the case that today's earnings were only "less bad" than it could have been. Dale Smothers still sees the stock as a strong dividend play. One bearish take he gives is America's Ozempic Effect" that will hit PepsiCo's snack profits.

Trading 360

17 Jul 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
8:00 pm
Market Overtime
replay
12:00 am
The Wrap
REPLAY
12:30 am
Market On Close
REPLAY
2:00 am
Trading 360
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
7:30 pm
Market Overtime
REPLAY
ON AIR
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
The Wrap
REPLAY